Last reviewed · How we verify
NCT01398319: AFIV
Prevention of Alcohol Related Incidents in the US Air Force
NA trial testing Group Brief Alcohol Intervention in Alcohol Abuse in 26,231 participants. Completed in 31 July 2018.
31 July 2018
Quick facts
| Lead sponsor | University of Virginia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 26,231 |
| Start date | 1 March 2016 |
| Primary completion | 31 July 2018 |
| Estimated completion | 31 July 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Group Brief Alcohol Intervention
- Group Brief Alcohol Intervention Booster
- Bystander Intervention
Conditions studied
- Alcohol Abuse — all drugs for Alcohol Abuse →
Sponsor
University of Virginia
Who can join
18 and older, any sex, with Alcohol Abuse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Alcohol misuse poses significant public health concerns in the U.S. military. A Brief Alcohol Intervention (BAI) have been shown to reduce alcohol related incidents among Airmen undergoing training. The current study sought to examine whether a booster BAI administered at the end of an Airmen's training reduced alcohol related incidents out to a one-year follow-up. Participants were 26,231 US Air Force Technical Trainees recruited between March 2016 and July 2018. Participants were cluster randomized by cohort to two conditions: BAI + BAI Booster or BAI + Bystander Intervention. The primary analysis was a comparison of the interventions' efficacies in preventing Article 15 alcohol related incidents at a one-year follow-up, conducted using a generalized estimating equations logistic regression model controlling for covariates.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Where, When, and How Alcohol Use Occurs During Air Force Technical Training.
Pebley K, Mallawaarachchi I, Talcott GW, Little MA. · · 2023 · PMID 34050674 · DOI 10.1093/milmed/usab206
Verify or expand the search:
- PubMed search for NCT01398319
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcohol Abuse
Currently open trials in the same condition.
- NCT07281261 — tAN for Substance Use Disorder · NA · recruiting
- NCT07216872 — Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use · NA · recruiting
- NCT06415721 — Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder · NA · recruiting
- NCT05743699 — Adaptation and Evaluation of Bright Horizons · NA · recruiting
- NCT06265506 — Virtual Incentive Treatment for Alcohol · NA · recruiting
Other University of Virginia trials
Trials by the same sponsor.
- NCT05880355 — Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI · EARLY_PHASE1 · not yet recruiting
- NCT07405645 — Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy · NA · recruiting
- NCT07146685 — Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study · Phase 4 · not yet recruiting
- NCT07298941 — Resilience Enhancement Following Sleep Treatment · Phase 2 · recruiting
- NCT07036315 — Meaning in Music-Based Pain Modulation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01398319 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Virginia
- Last refreshed: 26 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01398319.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing